A key aspect of the ability of CHI3L1 to modulate the GBM TME is based on its ability to form a protein complex with galectin-3 (Gal3) or galectin-3–binding protein (Gal3BP) to promote macrophage-mediated immune suppression [132]. This evidence concerns the gene CHI3L1 and glioblastoma.